US FDA rejects emergency use authorisation for Covaxin

| Jun 11, 2021, 12:45:42 PM | Times Now
  • Share
The US Food and Drug Administration has rejected Bharat Biotech’s proposal for an emergency use authorization of its Covid vaccine Covaxin. Ocugen, Bharat Biotech's US partner, on June 10 said the company will now be seeking a full approval of Covaxin.

Top Viral Videos

Short Videos